Pacific Financial Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Pacific Financial Group’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,548	Closed	-$246K	–	197
2014 Q4	$246K	Buy	+4,548	New	+$248K	0.07%	42
2014 Q2	–	Sell	-106,534	Closed	-$4.99M	–	66
2014 Q1	$4.99M	Buy	106,534 +85,456	+405%	+$4.04M	2.08%	10
2013 Q4	$927K	Sell	21,078 -108,930	-84%	-$4.54M	1.78%	14
2013 Q3	$5M	Buy	+130,008	New	+$4.92M	3.53%	9

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Pacific Financial Group's XPH Position: Q1 2015 in Review

Pacific Financial Group sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2015, closing a stake of 4,548 shares — an estimated $246K sold.

Pacific Financial Group first reported a position in XPH in Q3 2013 and held it in 4 quarters. The position peaked at $5M in Q3 2013. 79 funds tracked by Wall St. Rank hold XPH as of Q1 2015.

Pacific Financial Group reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2015 after selling out during the quarter.
Pacific Financial Group sold 4,548 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2015, an estimated $246K.
Pacific Financial Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2013 and held it in 4 quarters.
Pacific Financial Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $5M in Q3 2013.
79 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2015.

Based on Pacific Financial Group's 13F filing for Q1 2015, filed 27 Apr 2015.